Patient Reported Outcomes
Patient Reported Outcomes (PRO) research is at the core of Oxford Outcomes' service capability, and has been since the company's formation in 1997. Our PRO team is led by;
- Andrew Lloyd
- Diane Wild
- Kathy Beusterien
Our PRO practice leaders are actively involved in shaping science and regulation through their contributions to FDA policy development, the ISPOR leadership group, DIA SIACs, and the EUROQOL Group.
Our PRO team is comprised of senior and junior scientists based in Oxford and Bethesda. The team’s scientific skill base covers: PRO instrument development and psychometrics, statistical analysis, utility elicitation, patient preference, qualitative research methods, conceptual modeling, focus groups and interviews. The team’s knowledge and expertise covers: clinical development, regulatory affairs, labeling claims, scientific marketing, communication of results for scientific, regulatory, and marketing purposes.
Our PRO team utilizes a well-developed network of international opinion leaders, regulatory experts, and methodological and clinical experts as well as our collaborative relationships with a number of key researchers at the Universities of Oxford, Sheffield, Washington and York. We work hard at integrating this diverse range of scientific, commercial, and in-country expertise into our resource base. For more about our affiliations and networks click here.